nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—ABCB1—Lisinopril—systemic scleroderma	0.205	0.328	CbGbCtD
Mitomycin—ABCB1—Captopril—systemic scleroderma	0.154	0.246	CbGbCtD
Mitomycin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.121	0.194	CbGbCtD
Mitomycin—ABCB1—Prednisone—systemic scleroderma	0.0967	0.155	CbGbCtD
Mitomycin—ABCB1—Methotrexate—systemic scleroderma	0.0485	0.0776	CbGbCtD
Mitomycin—Somnolence—Pentoxifylline—systemic scleroderma	0.00136	0.00362	CcSEcCtD
Mitomycin—Vision blurred—Captopril—systemic scleroderma	0.00134	0.00356	CcSEcCtD
Mitomycin—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00133	0.00354	CcSEcCtD
Mitomycin—Ill-defined disorder—Captopril—systemic scleroderma	0.00132	0.00351	CcSEcCtD
Mitomycin—Anaemia—Captopril—systemic scleroderma	0.00131	0.0035	CcSEcCtD
Mitomycin—Extravasation—Methotrexate—systemic scleroderma	0.00131	0.00349	CcSEcCtD
Mitomycin—Malaise—Captopril—systemic scleroderma	0.00128	0.00341	CcSEcCtD
Mitomycin—Syncope—Captopril—systemic scleroderma	0.00127	0.00339	CcSEcCtD
Mitomycin—Renal failure—Lisinopril—systemic scleroderma	0.00126	0.00337	CcSEcCtD
Mitomycin—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00126	0.00336	CcSEcCtD
Mitomycin—Alopecia—Azathioprine—systemic scleroderma	0.00126	0.00335	CcSEcCtD
Mitomycin—Anorexia—Mometasone—systemic scleroderma	0.00126	0.00335	CcSEcCtD
Mitomycin—Loss of consciousness—Captopril—systemic scleroderma	0.00125	0.00332	CcSEcCtD
Mitomycin—Cough—Captopril—systemic scleroderma	0.00124	0.0033	CcSEcCtD
Mitomycin—Pulmonary oedema—Prednisone—systemic scleroderma	0.00121	0.00324	CcSEcCtD
Mitomycin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00121	0.00322	CcSEcCtD
Mitomycin—Ulcer—Methotrexate—systemic scleroderma	0.00121	0.00322	CcSEcCtD
Mitomycin—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0032	CcSEcCtD
Mitomycin—Discomfort—Captopril—systemic scleroderma	0.00119	0.00318	CcSEcCtD
Mitomycin—Alopecia—Leflunomide—systemic scleroderma	0.00119	0.00316	CcSEcCtD
Mitomycin—Dyspnoea—Mometasone—systemic scleroderma	0.00117	0.00313	CcSEcCtD
Mitomycin—Confusional state—Captopril—systemic scleroderma	0.00117	0.00311	CcSEcCtD
Mitomycin—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00115	0.00306	CcSEcCtD
Mitomycin—Decreased appetite—Mometasone—systemic scleroderma	0.00115	0.00306	CcSEcCtD
Mitomycin—Thrombophlebitis—Prednisone—systemic scleroderma	0.00114	0.00305	CcSEcCtD
Mitomycin—Anaemia—Azathioprine—systemic scleroderma	0.00114	0.00305	CcSEcCtD
Mitomycin—Shock—Captopril—systemic scleroderma	0.00114	0.00304	CcSEcCtD
Mitomycin—Fatigue—Mometasone—systemic scleroderma	0.00114	0.00303	CcSEcCtD
Mitomycin—Thrombocytopenia—Captopril—systemic scleroderma	0.00113	0.00302	CcSEcCtD
Mitomycin—Alopecia—Mycophenolic acid—systemic scleroderma	0.00113	0.00302	CcSEcCtD
Mitomycin—Pain—Mometasone—systemic scleroderma	0.00113	0.00301	CcSEcCtD
Mitomycin—Malaise—Azathioprine—systemic scleroderma	0.00112	0.00298	CcSEcCtD
Mitomycin—Leukopenia—Azathioprine—systemic scleroderma	0.00111	0.00296	CcSEcCtD
Mitomycin—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00295	CcSEcCtD
Mitomycin—Anorexia—Captopril—systemic scleroderma	0.0011	0.00294	CcSEcCtD
Mitomycin—Vision blurred—Leflunomide—systemic scleroderma	0.0011	0.00294	CcSEcCtD
Mitomycin—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00293	CcSEcCtD
Mitomycin—Asthenia—Pentoxifylline—systemic scleroderma	0.0011	0.00292	CcSEcCtD
Mitomycin—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00109	0.00291	CcSEcCtD
Mitomycin—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00108	0.00289	CcSEcCtD
Mitomycin—Anaemia—Leflunomide—systemic scleroderma	0.00108	0.00288	CcSEcCtD
Mitomycin—Malaise—Leflunomide—systemic scleroderma	0.00105	0.00281	CcSEcCtD
Mitomycin—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00105	0.0028	CcSEcCtD
Mitomycin—Leukopenia—Leflunomide—systemic scleroderma	0.00105	0.00279	CcSEcCtD
Mitomycin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00104	0.00279	CcSEcCtD
Mitomycin—Body temperature increased—Mometasone—systemic scleroderma	0.00104	0.00278	CcSEcCtD
Mitomycin—Discomfort—Azathioprine—systemic scleroderma	0.00104	0.00278	CcSEcCtD
Mitomycin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00103	0.00276	CcSEcCtD
Mitomycin—Dyspnoea—Captopril—systemic scleroderma	0.00103	0.00275	CcSEcCtD
Mitomycin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00103	0.00275	CcSEcCtD
Mitomycin—Somnolence—Captopril—systemic scleroderma	0.00103	0.00274	CcSEcCtD
Mitomycin—Cough—Leflunomide—systemic scleroderma	0.00102	0.00272	CcSEcCtD
Mitomycin—Alopecia—Lisinopril—systemic scleroderma	0.00102	0.00272	CcSEcCtD
Mitomycin—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00101	0.00271	CcSEcCtD
Mitomycin—Dizziness—Pentoxifylline—systemic scleroderma	0.00101	0.00269	CcSEcCtD
Mitomycin—Hypertension—Leflunomide—systemic scleroderma	0.00101	0.00269	CcSEcCtD
Mitomycin—Decreased appetite—Captopril—systemic scleroderma	0.00101	0.00268	CcSEcCtD
Mitomycin—Malaise—Mycophenolic acid—systemic scleroderma	0.00101	0.00268	CcSEcCtD
Mitomycin—Erythema—Lisinopril—systemic scleroderma	0.001	0.00268	CcSEcCtD
Mitomycin—Syncope—Mycophenolic acid—systemic scleroderma	0.001	0.00267	CcSEcCtD
Mitomycin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000998	0.00266	CcSEcCtD
Mitomycin—Fatigue—Captopril—systemic scleroderma	0.000998	0.00266	CcSEcCtD
Mitomycin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000989	0.00264	CcSEcCtD
Mitomycin—Discomfort—Leflunomide—systemic scleroderma	0.000983	0.00262	CcSEcCtD
Mitomycin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00098	0.00261	CcSEcCtD
Mitomycin—Cough—Mycophenolic acid—systemic scleroderma	0.000973	0.0026	CcSEcCtD
Mitomycin—Vomiting—Pentoxifylline—systemic scleroderma	0.000971	0.00259	CcSEcCtD
Mitomycin—Rash—Pentoxifylline—systemic scleroderma	0.000963	0.00257	CcSEcCtD
Mitomycin—Hypertension—Mycophenolic acid—systemic scleroderma	0.000963	0.00257	CcSEcCtD
Mitomycin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000962	0.00257	CcSEcCtD
Mitomycin—Headache—Pentoxifylline—systemic scleroderma	0.000957	0.00255	CcSEcCtD
Mitomycin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000956	0.00255	CcSEcCtD
Mitomycin—Feeling abnormal—Captopril—systemic scleroderma	0.000954	0.00254	CcSEcCtD
Mitomycin—Vision blurred—Lisinopril—systemic scleroderma	0.000946	0.00252	CcSEcCtD
Mitomycin—Asthenia—Mometasone—systemic scleroderma	0.000945	0.00252	CcSEcCtD
Mitomycin—Discomfort—Mycophenolic acid—systemic scleroderma	0.000938	0.0025	CcSEcCtD
Mitomycin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000934	0.00249	CcSEcCtD
Mitomycin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000932	0.00249	CcSEcCtD
Mitomycin—Anaemia—Lisinopril—systemic scleroderma	0.000928	0.00248	CcSEcCtD
Mitomycin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000917	0.00245	CcSEcCtD
Mitomycin—Body temperature increased—Captopril—systemic scleroderma	0.000915	0.00244	CcSEcCtD
Mitomycin—Oedema—Mycophenolic acid—systemic scleroderma	0.00091	0.00243	CcSEcCtD
Mitomycin—Anorexia—Leflunomide—systemic scleroderma	0.000909	0.00243	CcSEcCtD
Mitomycin—Nausea—Pentoxifylline—systemic scleroderma	0.000907	0.00242	CcSEcCtD
Mitomycin—Malaise—Lisinopril—systemic scleroderma	0.000906	0.00242	CcSEcCtD
Mitomycin—Diarrhoea—Mometasone—systemic scleroderma	0.000902	0.0024	CcSEcCtD
Mitomycin—Syncope—Lisinopril—systemic scleroderma	0.000901	0.0024	CcSEcCtD
Mitomycin—Leukopenia—Lisinopril—systemic scleroderma	0.000899	0.0024	CcSEcCtD
Mitomycin—Shock—Mycophenolic acid—systemic scleroderma	0.000895	0.00239	CcSEcCtD
Mitomycin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00238	CcSEcCtD
Mitomycin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000891	0.00238	CcSEcCtD
Mitomycin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000883	0.00235	CcSEcCtD
Mitomycin—Cough—Lisinopril—systemic scleroderma	0.000876	0.00234	CcSEcCtD
Mitomycin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000867	0.00231	CcSEcCtD
Mitomycin—Dyspnoea—Leflunomide—systemic scleroderma	0.00085	0.00227	CcSEcCtD
Mitomycin—Discomfort—Lisinopril—systemic scleroderma	0.000845	0.00225	CcSEcCtD
Mitomycin—Vomiting—Mometasone—systemic scleroderma	0.000838	0.00223	CcSEcCtD
Mitomycin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000832	0.00222	CcSEcCtD
Mitomycin—Rash—Mometasone—systemic scleroderma	0.000831	0.00222	CcSEcCtD
Mitomycin—Asthenia—Captopril—systemic scleroderma	0.00083	0.00222	CcSEcCtD
Mitomycin—Dermatitis—Mometasone—systemic scleroderma	0.00083	0.00221	CcSEcCtD
Mitomycin—Decreased appetite—Leflunomide—systemic scleroderma	0.000829	0.00221	CcSEcCtD
Mitomycin—Confusional state—Lisinopril—systemic scleroderma	0.000826	0.0022	CcSEcCtD
Mitomycin—Headache—Mometasone—systemic scleroderma	0.000825	0.0022	CcSEcCtD
Mitomycin—Fatigue—Leflunomide—systemic scleroderma	0.000822	0.00219	CcSEcCtD
Mitomycin—Oedema—Lisinopril—systemic scleroderma	0.00082	0.00219	CcSEcCtD
Mitomycin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000816	0.00218	CcSEcCtD
Mitomycin—Pain—Leflunomide—systemic scleroderma	0.000816	0.00218	CcSEcCtD
Mitomycin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000813	0.00217	CcSEcCtD
Mitomycin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000811	0.00216	CcSEcCtD
Mitomycin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000809	0.00216	CcSEcCtD
Mitomycin—Shock—Lisinopril—systemic scleroderma	0.000806	0.00215	CcSEcCtD
Mitomycin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000802	0.00214	CcSEcCtD
Mitomycin—Body temperature increased—Azathioprine—systemic scleroderma	0.000798	0.00213	CcSEcCtD
Mitomycin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000793	0.00212	CcSEcCtD
Mitomycin—Diarrhoea—Captopril—systemic scleroderma	0.000792	0.00211	CcSEcCtD
Mitomycin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000791	0.00211	CcSEcCtD
Mitomycin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000789	0.0021	CcSEcCtD
Mitomycin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000788	0.0021	CcSEcCtD
Mitomycin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000786	0.0021	CcSEcCtD
Mitomycin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000784	0.00209	CcSEcCtD
Mitomycin—Nausea—Mometasone—systemic scleroderma	0.000783	0.00209	CcSEcCtD
Mitomycin—Anorexia—Lisinopril—systemic scleroderma	0.000781	0.00208	CcSEcCtD
Mitomycin—Pain—Mycophenolic acid—systemic scleroderma	0.000778	0.00208	CcSEcCtD
Mitomycin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000773	0.00206	CcSEcCtD
Mitomycin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000768	0.00205	CcSEcCtD
Mitomycin—Dizziness—Captopril—systemic scleroderma	0.000765	0.00204	CcSEcCtD
Mitomycin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00203	CcSEcCtD
Mitomycin—Body temperature increased—Leflunomide—systemic scleroderma	0.000754	0.00201	CcSEcCtD
Mitomycin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00075	0.002	CcSEcCtD
Mitomycin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00197	CcSEcCtD
Mitomycin—Vomiting—Captopril—systemic scleroderma	0.000736	0.00196	CcSEcCtD
Mitomycin—Dyspnoea—Lisinopril—systemic scleroderma	0.000731	0.00195	CcSEcCtD
Mitomycin—Rash—Captopril—systemic scleroderma	0.00073	0.00195	CcSEcCtD
Mitomycin—Dermatitis—Captopril—systemic scleroderma	0.000729	0.00194	CcSEcCtD
Mitomycin—Somnolence—Lisinopril—systemic scleroderma	0.000729	0.00194	CcSEcCtD
Mitomycin—Headache—Captopril—systemic scleroderma	0.000725	0.00193	CcSEcCtD
Mitomycin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000724	0.00193	CcSEcCtD
Mitomycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000719	0.00192	CcSEcCtD
Mitomycin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00192	CcSEcCtD
Mitomycin—Decreased appetite—Lisinopril—systemic scleroderma	0.000712	0.0019	CcSEcCtD
Mitomycin—Fatigue—Lisinopril—systemic scleroderma	0.000707	0.00188	CcSEcCtD
Mitomycin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00188	CcSEcCtD
Mitomycin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000703	0.00188	CcSEcCtD
Mitomycin—Pain—Lisinopril—systemic scleroderma	0.000701	0.00187	CcSEcCtD
Mitomycin—Diarrhoea—Azathioprine—systemic scleroderma	0.000691	0.00184	CcSEcCtD
Mitomycin—Nausea—Captopril—systemic scleroderma	0.000687	0.00183	CcSEcCtD
Mitomycin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000684	0.00183	CcSEcCtD
Mitomycin—Asthenia—Leflunomide—systemic scleroderma	0.000684	0.00183	CcSEcCtD
Mitomycin—Pancytopenia—Methotrexate—systemic scleroderma	0.000679	0.00181	CcSEcCtD
Mitomycin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000675	0.0018	CcSEcCtD
Mitomycin—Dizziness—Azathioprine—systemic scleroderma	0.000668	0.00178	CcSEcCtD
Mitomycin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000653	0.00174	CcSEcCtD
Mitomycin—Diarrhoea—Leflunomide—systemic scleroderma	0.000653	0.00174	CcSEcCtD
Mitomycin—Body temperature increased—Lisinopril—systemic scleroderma	0.000648	0.00173	CcSEcCtD
Mitomycin—Vomiting—Azathioprine—systemic scleroderma	0.000642	0.00171	CcSEcCtD
Mitomycin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00171	CcSEcCtD
Mitomycin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000638	0.0017	CcSEcCtD
Mitomycin—Drowsiness—Methotrexate—systemic scleroderma	0.000638	0.0017	CcSEcCtD
Mitomycin—Rash—Azathioprine—systemic scleroderma	0.000637	0.0017	CcSEcCtD
Mitomycin—Dermatitis—Azathioprine—systemic scleroderma	0.000636	0.0017	CcSEcCtD
Mitomycin—Headache—Azathioprine—systemic scleroderma	0.000633	0.00169	CcSEcCtD
Mitomycin—Dizziness—Leflunomide—systemic scleroderma	0.000631	0.00168	CcSEcCtD
Mitomycin—Renal failure—Methotrexate—systemic scleroderma	0.000627	0.00167	CcSEcCtD
Mitomycin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000624	0.00167	CcSEcCtD
Mitomycin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000623	0.00166	CcSEcCtD
Mitomycin—Stomatitis—Methotrexate—systemic scleroderma	0.000622	0.00166	CcSEcCtD
Mitomycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00164	CcSEcCtD
Mitomycin—Vomiting—Leflunomide—systemic scleroderma	0.000606	0.00162	CcSEcCtD
Mitomycin—Alopecia—Prednisone—systemic scleroderma	0.000605	0.00162	CcSEcCtD
Mitomycin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000602	0.00161	CcSEcCtD
Mitomycin—Rash—Leflunomide—systemic scleroderma	0.000601	0.0016	CcSEcCtD
Mitomycin—Dermatitis—Leflunomide—systemic scleroderma	0.000601	0.0016	CcSEcCtD
Mitomycin—Nausea—Azathioprine—systemic scleroderma	0.0006	0.0016	CcSEcCtD
Mitomycin—Headache—Leflunomide—systemic scleroderma	0.000598	0.00159	CcSEcCtD
Mitomycin—Erythema—Prednisone—systemic scleroderma	0.000596	0.00159	CcSEcCtD
Mitomycin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000592	0.00158	CcSEcCtD
Mitomycin—Asthenia—Lisinopril—systemic scleroderma	0.000588	0.00157	CcSEcCtD
Mitomycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000579	0.00154	CcSEcCtD
Mitomycin—Rash—Mycophenolic acid—systemic scleroderma	0.000574	0.00153	CcSEcCtD
Mitomycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000573	0.00153	CcSEcCtD
Mitomycin—Headache—Mycophenolic acid—systemic scleroderma	0.00057	0.00152	CcSEcCtD
Mitomycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000568	0.00151	CcSEcCtD
Mitomycin—Nausea—Leflunomide—systemic scleroderma	0.000567	0.00151	CcSEcCtD
Mitomycin—Vision blurred—Prednisone—systemic scleroderma	0.000562	0.0015	CcSEcCtD
Mitomycin—Diarrhoea—Lisinopril—systemic scleroderma	0.000561	0.0015	CcSEcCtD
Mitomycin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000553	0.00148	CcSEcCtD
Mitomycin—Anaemia—Prednisone—systemic scleroderma	0.000551	0.00147	CcSEcCtD
Mitomycin—Dizziness—Lisinopril—systemic scleroderma	0.000542	0.00145	CcSEcCtD
Mitomycin—Nausea—Mycophenolic acid—systemic scleroderma	0.00054	0.00144	CcSEcCtD
Mitomycin—Malaise—Prednisone—systemic scleroderma	0.000538	0.00143	CcSEcCtD
Mitomycin—Syncope—Prednisone—systemic scleroderma	0.000535	0.00143	CcSEcCtD
Mitomycin—Loss of consciousness—Prednisone—systemic scleroderma	0.000524	0.0014	CcSEcCtD
Mitomycin—Vomiting—Lisinopril—systemic scleroderma	0.000521	0.00139	CcSEcCtD
Mitomycin—Rash—Lisinopril—systemic scleroderma	0.000517	0.00138	CcSEcCtD
Mitomycin—Dermatitis—Lisinopril—systemic scleroderma	0.000516	0.00138	CcSEcCtD
Mitomycin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000515	0.00137	CcSEcCtD
Mitomycin—Hypertension—Prednisone—systemic scleroderma	0.000515	0.00137	CcSEcCtD
Mitomycin—Headache—Lisinopril—systemic scleroderma	0.000513	0.00137	CcSEcCtD
Mitomycin—Alopecia—Methotrexate—systemic scleroderma	0.000506	0.00135	CcSEcCtD
Mitomycin—Discomfort—Prednisone—systemic scleroderma	0.000502	0.00134	CcSEcCtD
Mitomycin—Erythema—Methotrexate—systemic scleroderma	0.000498	0.00133	CcSEcCtD
Mitomycin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00131	CcSEcCtD
Mitomycin—Nausea—Lisinopril—systemic scleroderma	0.000487	0.0013	CcSEcCtD
Mitomycin—Oedema—Prednisone—systemic scleroderma	0.000487	0.0013	CcSEcCtD
Mitomycin—Shock—Prednisone—systemic scleroderma	0.000479	0.00128	CcSEcCtD
Mitomycin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000475	0.00127	CcSEcCtD
Mitomycin—Vision blurred—Methotrexate—systemic scleroderma	0.00047	0.00125	CcSEcCtD
Mitomycin—Anorexia—Prednisone—systemic scleroderma	0.000464	0.00124	CcSEcCtD
Mitomycin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000462	0.00123	CcSEcCtD
Mitomycin—Anaemia—Methotrexate—systemic scleroderma	0.000461	0.00123	CcSEcCtD
Mitomycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00122	CcSEcCtD
Mitomycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000453	0.00121	CcSEcCtD
Mitomycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00121	CcSEcCtD
Mitomycin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00045	0.0012	CcSEcCtD
Mitomycin—Malaise—Methotrexate—systemic scleroderma	0.000449	0.0012	CcSEcCtD
Mitomycin—Leukopenia—Methotrexate—systemic scleroderma	0.000446	0.00119	CcSEcCtD
Mitomycin—Cough—Methotrexate—systemic scleroderma	0.000435	0.00116	CcSEcCtD
Mitomycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00114	CcSEcCtD
Mitomycin—Decreased appetite—Prednisone—systemic scleroderma	0.000423	0.00113	CcSEcCtD
Mitomycin—Fatigue—Prednisone—systemic scleroderma	0.00042	0.00112	CcSEcCtD
Mitomycin—Discomfort—Methotrexate—systemic scleroderma	0.000419	0.00112	CcSEcCtD
Mitomycin—Confusional state—Methotrexate—systemic scleroderma	0.00041	0.00109	CcSEcCtD
Mitomycin—Feeling abnormal—Prednisone—systemic scleroderma	0.000401	0.00107	CcSEcCtD
Mitomycin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000398	0.00106	CcSEcCtD
Mitomycin—Anorexia—Methotrexate—systemic scleroderma	0.000388	0.00103	CcSEcCtD
Mitomycin—Body temperature increased—Prednisone—systemic scleroderma	0.000385	0.00103	CcSEcCtD
Mitomycin—Dyspnoea—Methotrexate—systemic scleroderma	0.000363	0.000967	CcSEcCtD
Mitomycin—Somnolence—Methotrexate—systemic scleroderma	0.000362	0.000965	CcSEcCtD
Mitomycin—Decreased appetite—Methotrexate—systemic scleroderma	0.000354	0.000943	CcSEcCtD
Mitomycin—Fatigue—Methotrexate—systemic scleroderma	0.000351	0.000936	CcSEcCtD
Mitomycin—Asthenia—Prednisone—systemic scleroderma	0.000349	0.000932	CcSEcCtD
Mitomycin—Pain—Methotrexate—systemic scleroderma	0.000348	0.000928	CcSEcCtD
Mitomycin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000335	0.000894	CcSEcCtD
Mitomycin—Diarrhoea—Prednisone—systemic scleroderma	0.000333	0.000888	CcSEcCtD
Mitomycin—Dizziness—Prednisone—systemic scleroderma	0.000322	0.000859	CcSEcCtD
Mitomycin—Body temperature increased—Methotrexate—systemic scleroderma	0.000322	0.000858	CcSEcCtD
Mitomycin—Vomiting—Prednisone—systemic scleroderma	0.000309	0.000826	CcSEcCtD
Mitomycin—Rash—Prednisone—systemic scleroderma	0.000307	0.000819	CcSEcCtD
Mitomycin—Dermatitis—Prednisone—systemic scleroderma	0.000307	0.000818	CcSEcCtD
Mitomycin—Headache—Prednisone—systemic scleroderma	0.000305	0.000813	CcSEcCtD
Mitomycin—Asthenia—Methotrexate—systemic scleroderma	0.000292	0.000779	CcSEcCtD
Mitomycin—Nausea—Prednisone—systemic scleroderma	0.000289	0.000771	CcSEcCtD
Mitomycin—Diarrhoea—Methotrexate—systemic scleroderma	0.000278	0.000742	CcSEcCtD
Mitomycin—Dizziness—Methotrexate—systemic scleroderma	0.000269	0.000718	CcSEcCtD
Mitomycin—Vomiting—Methotrexate—systemic scleroderma	0.000259	0.00069	CcSEcCtD
Mitomycin—Rash—Methotrexate—systemic scleroderma	0.000256	0.000684	CcSEcCtD
Mitomycin—Dermatitis—Methotrexate—systemic scleroderma	0.000256	0.000684	CcSEcCtD
Mitomycin—Headache—Methotrexate—systemic scleroderma	0.000255	0.00068	CcSEcCtD
Mitomycin—Nausea—Methotrexate—systemic scleroderma	0.000242	0.000645	CcSEcCtD
